These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7353334)

  • 1. Displacement of phenytoin from plasma binding sites by salicylate.
    Fraser DG; Ludden TM; Evens RP; Sutherland EW
    Clin Pharmacol Ther; 1980 Feb; 27(2):165-9. PubMed ID: 7353334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenytoin-salicylate interaction.
    Leonard RF; Knott PJ; Rankin GO; Robinson DS; Melnick DE
    Clin Pharmacol Ther; 1981 Jan; 29(1):56-60. PubMed ID: 7460475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salicylate clearance, the resultant of protein binding and metabolism.
    Furst DE; Tozer TN; Melmon KL
    Clin Pharmacol Ther; 1979 Sep; 26(3):380-9. PubMed ID: 466931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zomepirac--aspirin interactions in man.
    Desiraju RK; Nayak RK; Pritchard JF
    J Clin Pharmacol; 1984; 24(8-9):371-80. PubMed ID: 6480878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative plasma salicylate and urine salicylurate levels following administration of aspirin, magnesium salicylate, and choline magnesium trisalicylate.
    Mason WD
    J Pharm Sci; 1980 Nov; 69(11):1355-6. PubMed ID: 7452472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between valproic acid and aspirin in epileptic children: serum protein binding and metabolic effects.
    Orr JM; Abbott FS; Farrell K; Ferguson S; Sheppard I; Godolphin W
    Clin Pharmacol Ther; 1982 May; 31(5):642-9. PubMed ID: 6804150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of salicylate and aspirin in healthy volunteers: relevance to drug interaction on platelet function.
    Cerletti C; Bonati M; del Maschio A; Galletti F; Dejana E; Tognoni G; de Gaetano G
    J Lab Clin Med; 1984 Jun; 103(6):869-77. PubMed ID: 6726057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of salicylate during chronic aspirin therapy.
    Rumble RH; Brooks PM; Roberts MS
    Br J Clin Pharmacol; 1980 Jan; 9(1):41-5. PubMed ID: 7356892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of heparin or salicylate infusion on serum protein binding and on concentrations of phenytoin in serum, brain and cerebrospinal fluid of rats.
    Chou RC; Levy G
    J Pharmacol Exp Ther; 1981 Oct; 219(1):42-8. PubMed ID: 7288614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of aspirin on salivary and serum phenytoin kinetics in healthy subjects.
    Paxton JW
    Clin Pharmacol Ther; 1980 Feb; 27(2):170-8. PubMed ID: 7353335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of salicylate on the pharmacokinetics of phenytoin.
    Olanow CW; Finn AL; Prussak C
    Neurology; 1981 Mar; 31(3):341-2. PubMed ID: 7193826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration dependent plasma protein binding of salicylate in rheumatoid patients.
    Ekstrand R; Alvan G; Borga O
    Clin Pharmacokinet; 1979; 4(2):137-43. PubMed ID: 378501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of aspirin and salicylate in elderly subjects and in patients with alcoholic liver disease.
    Roberts MS; Rumble RH; Wanwimolruk S; Thomas D; Brooks PM
    Eur J Clin Pharmacol; 1983; 25(2):253-61. PubMed ID: 6628510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined phenytoin and salicylate effects on thyroid function tests.
    Baranetsky NG; Chertow BS; Webb MD; Leonard RF; Sivitz WI
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):166-76. PubMed ID: 3827407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of age, gender, and obesity on salicylate kinetics following single doses of aspirin.
    Greenblatt DJ; Abernethy DR; Boxenbaum HG; Matlis R; Ochs HR; Harmatz JS; Shader RI
    Arthritis Rheum; 1986 Aug; 29(8):971-80. PubMed ID: 3741521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salicylate removal during plasma exchange in normal volunteers.
    White RL; Garnett WR; Poynor WJ; Allen JH; Sharp DE
    Clin Pharm; 1984; 3(4):396-402. PubMed ID: 6467875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of aspirin formulation and dose on concentration of total salicylate in rat kidney.
    Leeling JL; Phillips BM; Kowalski TL; Kowalski RL
    J Pharm Sci; 1976 Mar; 65(3):447-50. PubMed ID: 1263101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic interaction between acetazolamide and salicylate: case reports and a pharmacokinetic explanation.
    Sweeney KR; Chapron DJ; Brandt JL; Gomolin IH; Feig PU; Kramer PA
    Clin Pharmacol Ther; 1986 Nov; 40(5):518-24. PubMed ID: 3769383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pharmacokinetic comparison of choline magnesium trisalicylate and soluble aspirin.
    Helliwell M; Gibson T; Berry D; Volans G
    Br J Rheumatol; 1984 Nov; 23(4):288-91. PubMed ID: 6487934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma salicylate concentrations in immature dogs following aspirin administration: comparison with adult dogs.
    Waters DJ; Bowers LD; Cipolle RJ; Caywood DD; Bill RL
    J Vet Pharmacol Ther; 1993 Sep; 16(3):275-82. PubMed ID: 8230398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.